Invention Grant
- Patent Title: Hydrogel encapsulated cells and anti-inflammatory drugs
-
Application No.: US16403183Application Date: 2019-05-03
-
Publication No.: US10709667B2Publication Date: 2020-07-14
- Inventor: Daniel G. Anderson , Robert S. Langer , Tram T. Dang
- Applicant: Massachusetts Institute of Technology , The Children's Medical Center Corporation
- Applicant Address: US MA Cambridge US MA Boston
- Assignee: MASSACHUSETTS INSTITUTE OF TECHNOLOGY,THE CHILDREN'S MEDICAL CENTER CORPORATION
- Current Assignee: MASSACHUSETTS INSTITUTE OF TECHNOLOGY,THE CHILDREN'S MEDICAL CENTER CORPORATION
- Current Assignee Address: US MA Cambridge US MA Boston
- Agency: Pabst Patent Group LLP
- Main IPC: A61K9/16
- IPC: A61K9/16 ; A61K9/00 ; A61K31/573 ; A61K45/06 ; A61K35/39 ; G01N33/50 ; A61L27/38 ; A61L27/48 ; A61L27/52 ; A61L27/54 ; C12N5/071

Abstract:
A composition containing biocompatible hydrogel encapsulating mammalian cells and anti-inflammatory drugs is disclosed. The encapsulated cells have reduced fibrotic overgrowth after implantation in a subject. The compositions contain a biocompatible hydrogel having encapsulated therein mammalian cells and anti-inflammatory drugs or polymeric particles loaded with anti-inflammatory drugs. The anti-inflammatory drugs are released from the composition after transplantation in an amount effective to inhibit fibrosis of the composition for at least ten days. Methods for identifying and selecting suitable anti-inflammatory drug-loaded particles to prevent fibrosis of encapsulated cells are also described. Methods of treating a disease in a subject are also disclosed that involve administering a therapeutically effective amount of the disclosed encapsulated cells to the subject.
Public/Granted literature
- US20190254975A1 HYDROGEL ENCAPSULATED CELLS AND ANTI-INFLAMMATORY DRUGS Public/Granted day:2019-08-22
Information query